Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 194,719 | 616,931 | 123,490 | 197,292 | 47,010 |
| Marketable Securities | 512,281 | 325,443 | 459,361 | 315,586 | 247,380 |
| Receivables | 235,217 | 125,036 | 74,228 | 48,814 | 45,590 |
| Inventories | 98,102 | 51,628 | 39,280 | 20,562 | 20,950 |
| Income taxes - deferred | 197,567 | N/A | N/A | N/A | N/A |
| Other current assets | 0 | 50,000 | 0 | 0 | 11,050 |
| TOTAL | $1,265,898 | $1,183,760 | $707,759 | $593,798 | $371,980 |
| Non-Current Assets | |||||
| PPE Net | 198,200 | 67,727 | 62,828 | 55,174 | 51,390 |
| Other Non-Current Assets | 90,624 | 36,696 | 24,199 | 29,127 | 13,420 |
| TOTAL | $288,824 | $104,423 | $87,027 | $84,301 | $64,810 |
| Total Assets | $1,554,722 | $1,288,183 | $794,786 | $678,099 | $436,800 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 139 | 194 | 1,492 | 3,034 | 3,190 |
| Accounts payable and accrued liabilities | 35,649 | 24,406 | 19,174 | 11,605 | 9,480 |
| Accrued Expenses | 47,631 | 28,574 | 30,626 | 19,920 | 30,370 |
| Other current liabilities | N/A | N/A | N/A | N/A | 4,830 |
| TOTAL | $185,895 | $104,892 | $80,117 | $58,238 | $47,870 |
| Non-Current Liabilities | |||||
| Long Term Debt | 323 | 273 | 389 | 2,238 | 5,250 |
| Deferred Revenues | 5,474 | 7,692 | 3,996 | 4,355 | N/A |
| aiOther Non-Current Liabilities | 345,000 | 595,000 | 254,591 | 255,769 | 86,380 |
| TOTAL | $365,853 | $611,950 | $262,232 | $268,737 | $91,630 |
| Total Liabilities | $551,748 | $716,842 | $342,349 | $326,975 | $139,510 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,710,246 | 1,588,027 | 1,551,994 | 1,509,653 | N/A |
| Common Shares | 426 | 198 | 193 | 189 | 40 |
| Retained earnings | -453,643 | -381,640 | -453,737 | -506,008 | -449,230 |
| Other shareholders' equity | 3,201 | 2,475 | 7,448 | -904 | -2,600 |
| TOTAL | $1,002,974 | $571,341 | $452,437 | $351,124 | $297,290 |
| Total Liabilities And Equity | $1,554,722 | $1,288,183 | $794,786 | $678,099 | $436,800 |